Abstract
Aim: Identification of microRNAs (miRNAs) associated with atherosclerosis may unravel novel therapeutic targets and biomarkers. We studied miRNAs differentially expressed between coronary atherosclerotic plaques (CAP) and healthy arteries. Materials & methods: Paired CAP and internal mammary arteries (IMA) were collected from 14 coronary artery disease patients. The miRNA profiles between diseased (CAP) and healthy (IMA) tissues were compared using microarrays and quantitative PCR. Results: Thirty-one miRNAs were differentially expressed between CAP and IMA. Among these, miR-486-5p showed a high level of regulation (12-fold), had predicted interactions with atherosclerosis-associated genes and correlated with triglyceride levels and arterial stenosis. Regulation of miR-486-5p was validated by PCR (p = 0.004). Conclusion: The miRNAs are regulated in the atherosclerotic plaque. We highlight miR-486-5p whose role in atherosclerosis requires further investigation.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . Recent insights into the cellular biology of atherosclerosis. J. Cell Biol. 209, 13–22 (2015).
- 2. . Inflammation and plaque vulnerability. J. Intern. Med. 278, 483–493 (2015).
- 3. . Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116, 1832–1844 (2007).
- 4. Macrophages create an acidic extracellular hydrolytic compartment to digest aggregated lipoproteins. Mol. Biol. Cell 20, 4932–4940 (2009).
- 5. . Dynamic aspects of macrophage polarization during atherosclerosis progression and regression. Front. Immunol. 5, 579 (2014).
- 6. . Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol. Rev. 96, 1297–1325 (2016). • Overview of the role of microRNAs as biomarkers.
- 7. . miRNAs as biomarkers of myocardial infarction: a step forward towards personalized medicine? Trends Mol. Med. 20, 716–725 (2014). • Overview of the role of microRNAs as biomarkers.
- 8. . Impact of miRNA in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 38, e159–e170 (2018).
- 9. Use of circulating microRNAs to diagnose acute myocardial infarction. Clin. Chem. 58, 559–567 (2012).
- 10. . Prognostic microRNAs after AMI. Circ. Res. 113, e46–e47 (2013).
- 11. Diagnostic and prognostic value of circulating microRNAs in patients with acute chest pain. J. Intern. Med. 277, 260–271 (2015).
- 12. Prospective study on circulating microRNAs and risk of myocardial infarction. J. Am. Coll. Cardiol. 60, 290–299 (2012).
- 13. A unique microRNA signature associated with plaque instability in humans. Stroke 42, 2556–2563 (2011). •• Addresses the association of microRNAs with atherosclerosis.
- 14. MicroRNA deregulation in symptomatic carotid plaque. J. Vasc. Surg. 62, 1245–1250 (2015). •• Addresses the association of microRNAs with atherosclerosis.
- 15. MicroRNA expression profile of human advanced coronary atherosclerotic plaques. Sci. Rep. 8, 7823 (2018). •• Addresses the association of microRNAs with atherosclerosis.
- 16. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
- 17. R: A Language and Environment for Statistical Computing, In: R Foundation for Statistical Computing (2017). https://www.R-project.org/
- 18. . KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000).
- 19. . Predicting effective microRNA target sites in mammalian mRNAs. Elife 4, e05005 (2015).
- 20. DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Res. 41, W169–W173 (2013).
- 21. . miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 43, D146–D152 (2015).
- 22. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
- 23. . WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).
- 24. Long non-coding RNAs in the atherosclerotic plaque. Atherosclerosis 266, 176–181 (2017). • Addresses the association of another class of noncoding RNAs (long noncoding RNAs), with atherosclerosis. The same samples as for the present study were used in this investigation.
- 25. MiR-486 and miR-92a identified in circulating HDL discriminate between stable and vulnerable coronary artery disease patients. PLoS ONE 10, e0140958 (2015). •• Addresses the modulation of the miR-486-5p in the serum of coronary artery patients which could reinforce its use as disease marker.
- 26. Inhibition of miR-486 and miR-92a decreases liver and plasma cholesterol levels by modulating lipid-related genes in hyperlipidemic hamsters. Mol. Biol. Rep. 45, 497–509 (2018).
- 27. . Disabled-2 (Dab2) mediates transforming growth factor beta (TGFbeta)-stimulated fibronectin synthesis through TGFbeta-activated kinase 1 and activation of the JNK pathway. J. Biol. Chem. 280, 25920–25927 (2005).
- 28. TGF-beta-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-beta1-induced MKK3-p38 MAPK activation and stimulation of type I collagen. Am. J. Physiol. Renal Physiol. 292, F1471–F1478 (2007).
- 29. . TGF-beta-activated kinase-1: new insights into the mechanism of TGF-beta signaling and kidney disease. Kidney Res. Clin. Pract. 31, 94–105 (2012).
- 30. . Interplay between NF-kappaB and Kruppel-like factors in vascular inflammation and atherosclerosis: location, location, location. J. Am. Heart Assoc. 2, e000290 (2013).
- 31. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J. Exp. Med. 203, 2073–2083 (2006).
- 32. . Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332, 73–78 (2006).
- 33. . MiR-486-5p regulates pancreatic β cell function in type 2 diabetes mellitus by targeting PTEN and FOXO1. Pharmazie 73, 477–481 (2018).
- 34. Circulating microRNA-320a and microRNA-486 predict thiazolidinedione response: moving towards precision health for diabetes prevention. Metabolism 64, 1051–1059 (2015).
- 35. . MiR-106b-5p inhibits tumor necrosis factor-alpha-induced apoptosis by targeting phosphatase and tensin homolog deleted on chromosome 10 in vascular endothelial cells. Chin. Med. J. 129, 1406–1412 (2016).
- 36. . Endothelial microRNAs and atherosclerosis. Curr. Atheroscler. Rep. 15, 372 (2013).
- 37. Endothelial microparticles-mediated transfer of microRNA-19b promotes atherosclerosis via activating perivascular adipose tissue inflammation in apoE(-/-) mice. Biochem. Biophys. Res. Commun. 495, 1922–1929 (2018).